Ken Griffin Royalty Pharma PLC Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 125,900 shares of RPRX stock, worth $3.56 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125,900
Previous 81,300
54.86%
Holding current value
$3.56 Million
Previous $2.47 Million
34.43%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RPRX
# of Institutions
397Shares Held
291MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.25 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$650 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$462 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$338 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...